Consequently, the growth rate of PAX6-overexpressing tumors was partially reduced, as evidenced by changes in tumor weights and volumes (Figure 6A–D), demonstrating the inhibitory effect of PAX6 overexpression on glioma growth in vivo. The gene discussed is PAX6; the disease is central nervous system cancer.